AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 3 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,231 | -31.7% | 17,696 | -30.3% | 0.00% | -50.0% |
Q2 2023 | $60,395 | +109709.1% | 25,376 | -14.6% | 0.00% | 0.0% |
Q1 2023 | $55 | +52.8% | 29,728 | +55.4% | 0.00% | +100.0% |
Q4 2022 | $36 | -99.7% | 19,125 | +193.9% | 0.00% | – |
Q3 2022 | $14,000 | +40.0% | 6,507 | +88.4% | 0.00% | – |
Q2 2022 | $10,000 | -23.1% | 3,454 | +16.1% | 0.00% | – |
Q1 2022 | $13,000 | -43.5% | 2,974 | -32.4% | 0.00% | – |
Q4 2021 | $23,000 | -42.5% | 4,400 | -27.2% | 0.00% | -100.0% |
Q3 2021 | $40,000 | +135.3% | 6,048 | +133.9% | 0.00% | – |
Q2 2021 | $17,000 | 0.0% | 2,586 | -16.0% | 0.00% | – |
Q1 2021 | $17,000 | +21.4% | 3,080 | +91.1% | 0.00% | – |
Q4 2020 | $14,000 | -77.0% | 1,612 | -69.0% | 0.00% | -100.0% |
Q3 2020 | $61,000 | +335.7% | 5,203 | +484.6% | 0.00% | 0.0% |
Q2 2020 | $14,000 | +250.0% | 890 | +41.0% | 0.00% | – |
Q1 2020 | $4,000 | -86.2% | 631 | -71.7% | 0.00% | -100.0% |
Q4 2019 | $29,000 | -69.8% | 2,227 | -26.8% | 0.00% | -66.7% |
Q1 2019 | $96,000 | +4700.0% | 3,041 | +4372.1% | 0.01% | – |
Q3 2018 | $2,000 | – | 68 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,283,966 | $15,166,000 | 1.40% |
Sio Capital Management, LLC | 591,870 | $3,930,000 | 0.98% |
TFG Asset Management GP Ltd | 2,500,000 | $16,600,000 | 0.90% |
Ikarian Capital, LLC | 1,356,048 | $9,004,000 | 0.73% |
SABBY MANAGEMENT, LLC | 400,050 | $2,656,000 | 0.37% |
Nantahala Capital Management | 1,793,500 | $11,909,000 | 0.34% |
Regency Capital Management Inc.\DE | 57,000 | $378,000 | 0.29% |
Eversept Partners, LP | 473,074 | $3,141,211 | 0.21% |
MYDA Advisors LLC | 85,000 | $564,000 | 0.14% |
Henry James International Management Inc. | 54,047 | $359,000 | 0.10% |